Metraipolis › archive › dc_d656b01fbed1

Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and… — Europe PMC PMID:40830610

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40830610
DOI
10.1007/s00228-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-10T12:15:04.936Z
SHA-256 of the archived text
d6cc32de0404a2eff6c91b574dbcf765c7bb76854ae8e5f2fac543ed46f6762b
Stable URL of this page
https://metraipolis.com/documento/dc_d656b01fbed1

How to cite

Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and… — Europe PMC PMID:40830610 — Europe PMC (en), https://europepmc.org/article/MED/40830610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d656b01fbed1 (Metraipolis archive dc_d656b01fbed1, sha256 d6cc32de0404a2eff6c91b574dbcf765c7bb76854ae8e5f2fac543ed46f6762b)
BibTeX
@misc{dcd656b01fbed1,
  title = {Optimizing therapeutic drug monitoring of mirtazapine - applying therapeutic reference range, concentration-dose ratio/dose-related concentration, and… — Europe PMC PMID:40830610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40830610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d656b01fbed1; sha256 d6cc32de0404a2eff6c91b574dbcf765c7bb76854ae8e5f2fac543ed46f6762b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830610. Agents can read the archived copy with the MCP tool read_document.